Holen Sie sich die Stockscreener-App
4.71
0.63%
-0.03
Handel nachbörslich:
4.64
-0.07
-1.49%
Finanzdaten der Salarius Pharmaceuticals Inc-Aktie (SLRX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
43.82%
0.9656
|
1.7187 | 1.4887 | 1.0065 | 1.4675 |
| Operating Income/Loss |
43.82%
-0.9656
|
-1.7187 | -1.4887 | -1.0065 | -1.4675 |
| Income/Loss From Continuing Operations Before Tax |
43.97%
-0.9578
|
-1.7095 | -1.4639 | -0.9721 | -1.4244 |
| Income/Loss From Continuing Operations After Tax |
43.97%
-0.9578
|
-1.7095 | -1.4639 | -0.9721 | -1.4244 |
|
Net Income/Loss
|
43.97%
-0.9578
|
-1.7095 | -1.4639 | -0.9721 | -1.4244 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
27.58%
2.1229
|
1.6639 | 0.1608 | 1.2819 | 0.6004 |
| Diluted Average Shares |
27.58%
2.1229
|
1.6639 | 0.1608 | 1.2819 | 0.6004 |
| Basic Earnings Per Share |
56.31%
-0.45
|
-1.03 | -0.66 | -0.76 | -2.37 |
| Diluted Earnings Per Share |
56.31%
-0.45
|
-1.03 | -0.66 | -0.76 | -2.37 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):